These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 18431839)
1. Safety of very tight glucose control in type 2 diabetes in question. Idris I Diabetes Obes Metab; 2008 May; 10(5):438. PubMed ID: 18431839 [No Abstract] [Full Text] [Related]
3. [Intensive therapy in type 2 diabetes. More damage than benefit?]. Einecke D MMW Fortschr Med; 2008 Jun; 150(26-27):12-4. PubMed ID: 18681224 [No Abstract] [Full Text] [Related]
4. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes. Martin CL Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803 [No Abstract] [Full Text] [Related]
5. [Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough]. Reblin T; Seidel D; Stein D; Görtz A; Lander T MMW Fortschr Med; 2003 May; 145(19):41. PubMed ID: 12813977 [No Abstract] [Full Text] [Related]
6. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study]. Füchtenbusch M; Hummel M MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157 [No Abstract] [Full Text] [Related]
7. Is Hemoglobin A1c the Right Outcome for Studies of Diabetes? Lipska KJ; Krumholz HM JAMA; 2017 Mar; 317(10):1017-1018. PubMed ID: 28125758 [No Abstract] [Full Text] [Related]
8. A summary of the ADVANCE Trial. Heller SR; Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S357-61. PubMed ID: 19875581 [No Abstract] [Full Text] [Related]
9. Update on the Canadian Diabetes Association 2008 clinical practice guidelines. Bhattacharyya OK; Estey EA; Cheng AY; Can Fam Physician; 2009 Jan; 55(1):39-43. PubMed ID: 19155364 [No Abstract] [Full Text] [Related]
10. Individualizing glycemic targets in type 2 diabetes mellitus. Aron D; Conlin PR; Hobbs C; Vigersky RA; Pogach L Ann Intern Med; 2011 Sep; 155(5):340-1. PubMed ID: 21893635 [No Abstract] [Full Text] [Related]
11. Type 2 diabetes and HbA1c targets. Prescrire Int; 2008 Dec; 17(98):254. PubMed ID: 19425272 [TBL] [Abstract][Full Text] [Related]
12. [New studies, new strategies, new guidelines: so that diabetic patients will live longer]. Aumiller J MMW Fortschr Med; 2005 Oct; 147(41):4-6. PubMed ID: 16270500 [No Abstract] [Full Text] [Related]
14. Glycaemic control in diabetes. Herman W Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678 [No Abstract] [Full Text] [Related]
15. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Turner R; Cull C; Holman R Ann Intern Med; 1996 Jan; 124(1 Pt 2):136-45. PubMed ID: 8554206 [TBL] [Abstract][Full Text] [Related]
16. Very tight glucose control: May be high risk, low benefit. Yudkin JS BMJ; 2008 Mar; 336(7646):683. PubMed ID: 18369208 [No Abstract] [Full Text] [Related]
17. Optimizing diabetes management through glucose profiling: a case-based approach. Streja DA Prim Care Diabetes; 2008 Dec; 2(4):167-73. PubMed ID: 18786873 [TBL] [Abstract][Full Text] [Related]
18. Tight control of blood glucose in long standing type 2 diabetes. Lehman R; Krumholz HM BMJ; 2009 Mar; 338():b800. PubMed ID: 19264821 [No Abstract] [Full Text] [Related]